[Problems of arteriosclerosis epidemiology. Analysis of risk factors with a view to a possible therapy].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000453:epidemiology* / Q000628:therapy; D001241:Aspirin / Q000627:therapeutic use; D001791:Blood Platelet Disorders / Q000150:complications; D002792:Cholestyramine Resin / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D048909:Diabetes Complications; D004038:Diet, Reducing; D005060:Europe; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D009539:Nicotinic Acids / Q000627:therapeutic use; D009656:North America; D009765:Obesity / Q000150:complications; D010743:Phospholipids / Q000627:therapeutic use; D010974:Platelet Aggregation; D012907:Smoking / Q000150:complications
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D000959:Antihypertensive Agents; D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D010743:Phospholipids; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D001241:Aspirin
Problemi di epidemiologia dell'arteriosclerosi. Analisi dei fattori di rischio in vista di una possibile terapia